Swiss NGO Terre des hommes loses $10m from US aid freeze
Select your language
Generated with artificial intelligence.
Listening: Swiss NGO Terre des hommes loses $10m from US aid freeze
The Swiss-based NGO Terre des hommes is losing $10 million in annual contributions as a result of the suspension of humanitarian aid by the United States administration.
This content was published on
2 minutes
Keystone-SDA
Français
fr
Coupe américaine: Terre des hommes perd 10 millions
Original
US President Donald Trump’s decision to dismantle the US Agency for International Development (USAID) has “serious” and “immediate” consequences, said Terre des hommes Lausanne, which is Switzerland’s largest children’s aid organisation.
The NGO explains that projects in nine countries have been affected, with around 1.5 million beneficiaries losing “vital support”.
In detail, projects in Bangladesh, Kenya, Lebanon, Egypt, Afghanistan, India and Burkina Faso are directly affected. Due to the cessation of contributions to UN partner organisations, activities in Romania and Nigeria are also affected.
The end of US aid also means that the contracts of 440 employees, including over 200 in Bangladesh and more than 100 in Egypt, have had to be suspended or terminated.
More
More
Proposed Swiss cuts to international aid mean less for the needy
This content was published on
The Swiss government’s major savings project is giving international cooperation organisations cold sweats.
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Banking & Fintech
UBS releases ‘hundreds’ of staff in fresh wave of job cuts
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
Explosion in global patents for transport innovations
This content was published on
The number of patents for transport innovations has exploded in the last 20 years, rising 700% to 120,000 by 2023, says WIPO.
Milei orders Argentina’s withdrawal from the World Health Organization
This content was published on
Argentina’s president, Javier Milei, has announced plans to pull the country out of the Geneva-headquartered World Health Organization (WHO).
‘Europe’ initiative halts signature collection to focus on Swiss-EU treaty
This content was published on
The initiative sought to embed Swiss-EU relations in the Federal Constitution, but the organisers have now stopped signature collection.
Swiss study sheds light on link between obesity and metabolic diseases
This content was published on
ETH Zurich researchers collected cells from overweight individuals to identify biological markers that raise the risk of metabolic diseases.
Swiss retail sector sees slight decline despite strong online sales
This content was published on
Black Friday, which performed well in some areas of Switzerland, and Christmas sales could not make up for the losses of previous months.
Over 6,000 Swiss companies go bankrupt but start-ups see growth
This content was published on
Switzerland recorded a spike in bankruptcies last year, but there was also a rise in new start-ups. Trends varied significantly by region and sector.
Basel greenlights funding for Eurovision Village 2025
This content was published on
MCH Group Ltd. is set to receive CHF1 million ($1.1 million) for the Eurovision Village at the Eurovision Song Contest 2025 in Basel.
Geneva researchers discover potential for targeted cancer drug delivery
This content was published on
Researchers in Geneva have discovered how some bacteria inject dangerous enzymes into cells, potentially enabling targeted drug delivery to cancer cells.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.